Identification of rat OX40 ligand by molecular cloning

被引:21
|
作者
Akiba, H
Atsuta, M
Yagita, H
Okumura, K
机构
[1] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Japan Sci & Technol Corp, CREST, Chiyoda Ku, Tokyo 1010062, Japan
关键词
D O I
10.1006/bbrc.1998.9376
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
OX40 (CD134) is a member of the tumor necrosis factor (TNF) receptor superfamily first identified as a rat T cell activation marker. In the present study, we identified the rat Ligand for OX40 (OX40L) by molecular cloning. Rat OX40L cDNA was cloned from a HTLV-1-transformed rat T cell line by cross-hybridization with mouse OX40L cDNA. The predicted rat OX40L polypeptide is composed of 199 amino acids, showing 80.9 and 43.3% homology to mouse and human OX40L, respectively. Expression of rat OX40L mRNA was found in HTLV-1-transformed rat T cell lines. Expression of OX40L on the cell surface of these HTLV-1-transformed rat T cell lines was also demonstrated by flow cytometric analysis with a soluble fusion protein composed of the extracellular region of the Fc portion of human IgG (OX40-Ig). To explore the function of rat OX40L, we generated cDNA transfectants stably expressing rat OX40L. The rat OX40L transfectants exhibited a potent costimulatory activity for proliferation and IL-2 production of anti-CD3-stimulated rat T cells. These results indicated that rat OX40L can provide an efficient costimulation for rat T cells and that it may be involved in HTLV-1-associated pathologies in the rat system as has been suggested in the human system. (C) 1998 Academic Press.
引用
收藏
页码:131 / 136
页数:6
相关论文
共 50 条
  • [41] Spontaneous pulmonary hypertension in mice associated with OX40 ligand overexpression
    Rabieyousefi, Moloud
    Zhang, Ming-Cai
    Soroosh, Pejman
    Ishii, Naoto
    Sugamura, Kazuo
    Ono, Masao
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [42] OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses
    Ishii, N
    Ndhlovu, LC
    Murata, K
    Sato, T
    Kamanaka, M
    Sugamura, K
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (09) : 2372 - 2381
  • [43] OX40 ligand is inhibitory during the effector phase of crescentic glomerulonephritis
    Odobasic, Dragana
    Ruth, Amanda J.
    Oudin, Virginie
    Kitching, A. Richard
    Holdsworth, Stephen R.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (03) : 429 - 441
  • [44] OX40/OX40L与疾病
    刘纯
    王玉亮
    医学综述, 2011, 17 (15) : 2271 - 2273
  • [45] Role of OX40 and its ligand as costimulatory modulators in cancer immunotherapy
    Sani, Aliya, I
    Zil-e-Rubab
    Usman, Shumaila
    Ahmed, Syed Zaryab
    Hosein, Mervyn
    AIMS MOLECULAR SCIENCE, 2021, 8 (03): : 161 - 173
  • [46] Identification of Novel Mechanisms of Tolerance Resistance Induced By OX40
    Shi, X.
    Fang, Z.
    Ghobrial, R.
    Xiao, X.
    Li, X.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 39 - 39
  • [47] Functional CD4 T cells after intercellular molecular transfer of OX40 ligand
    Baba, E
    Takahashi, Y
    Lichtenfeld, J
    Tanaka, R
    Yoshida, A
    Sugamura, K
    Yamamoto, N
    Tanaka, Y
    JOURNAL OF IMMUNOLOGY, 2001, 167 (02): : 875 - 882
  • [48] Characterisation of chicken OX40 and OX40L
    Scherer, Stephanie
    Goebel, Thomas W.
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2018, 82 : 128 - 138
  • [49] OX40 and OX40L Interaction in Cancer
    Lu, Xinjie
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (28) : 5659 - 5673
  • [50] Human OX40 ligand fusion protein (MEDI6383) as a potent OX40 agonist and immuno-modulator in vitro and in vivo.
    Hammond, Scott A.
    Morris, Chad
    Auge, Catherine
    Du, Qun
    Mulgrew, Kathy
    McGlinchey, Kelly
    Eck, Steven
    Buss, Nicholas
    Hair, James
    Stracener, Christina
    De Haan, Lolke
    Damschroder, Melissa
    Weinberg, Andrew
    Oberst, Michael D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)